CBIO Q3 2023 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$345M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$269,937

Operating Income

-$10M

Net Income

-$9M

EPS (Diluted)

$-0.14

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$53M

Total Liabilities

$7M

Stockholders' Equity

$47M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$269,937	-$256,031	-5.4%
Operating Income	-$10M	-$9M	-11.9%
Net Income	-$9M	-$9M	-8.0%